| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.6M | +47.7% |
| Cost of Revenue | $2.6M | +420.0% |
| R&D Expense | $11.8M | -41.7% |
| SG&A Expense | $58.8M | +24.3% |
| Operating Income | -$65.9M | -0.2% |
| Income Tax | $0 | — |
| Net Income | -$76.6M | -14.3% |
| EPS (Basic) | -$1.48 | +0.0% |
| EPS (Diluted) | -$1.48 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $46.3M | -33.4% |
| Accounts Receivable | $48K | -98.9% |
| Inventory | $2.5M | +141.0% |
| Current Assets | $51.2M | -34.0% |
| Total Assets | $54.1M | -33.7% |
| Current Liabilities | $29.0M | +70.4% |
| Long-term Debt | $31.0M | -27.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$60.9M | -57.9% |
| Capital Expenditures | $27K | -92.5% |
| Investing Cash Flow | -$19K | +94.8% |
| Financing Cash Flow | $37.7M | -49.2% |
| Free Cash Flow | -$61.0M | -56.5% |
| +0.0% |
| Total Liabilities |
| $64.0M |
| +3.5% |
| Stockholders' Equity | -$9.9M | -149.9% |